Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C5H10O5 |
| Molecular Weight | 150.1301 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 3 / 3 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OC[C@@H](O)[C@@H](O)[C@H](O)C=O
InChI
InChIKey=PYMYPHUHKUWMLA-WDCZJNDASA-N
InChI=1S/C5H10O5/c6-1-3(8)5(10)4(9)2-7/h1,3-5,7-10H,2H2/t3-,4-,5+/m1/s1
| Molecular Formula | C5H10O5 |
| Molecular Weight | 150.1301 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 3 / 3 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
D-Arabinose (D-Ara) is a reducing rare sugar. It is a substrate for by D-arabinose dehydrogenase (ARA) and participated in D-erythroascorbic acid synthesis in S. cerevisiae. D-Erythroascorbic acid (eAsA) is an important antioxidant molecule in yeast. It was found, that ARA 2p, not ARA 1p, mainly contributes to the production of eAsA. Recently was published the first report of biological of D-Ara. It was compared the growth inhibitory effects of aldohexose stereoisomers against the animal model Caenorhabditis elegans cultured in monoxenic conditions with Escherichia coli as food. The inhibitory effect of D-Ara was also observed in animals cultured in axenic conditions using a chemically defined medium; this excluded the possible influence of E. coli. Among these stereoisomers, the D-Ara showed particularly strong growth inhibition. The assumption was made pointing, that the inhibition could be induced by multiple mechanisms, for example, disturbance of D-ribose and D-fructose metabolism.
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: Q04212 Gene ID: 855057.0 Gene Symbol: ARA2 Target Organism: Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast) Sources: https://www.ncbi.nlm.nih.gov/pubmed/17097644 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
PubMed
| Title | Date | PubMed |
|---|---|---|
| Growth inhibitory effect of D-arabinose against the nematode Caenorhabditis elegans: Discovery of a novel bioactive monosaccharide. | 2016-02-01 |
|
| NAD+-specific D-arabinose dehydrogenase and its contribution to erythroascorbic acid production in Saccharomyces cerevisiae. | 2006-11-27 |
|
| D-arabinose dehydrogenase and its gene from Saccharomyces cerevisiae. | 1998-12-08 |
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/26791015
D-arabinose (D-Ara) showed particularly strong growth inhibition against the nematode Caenorhabditis elegans. The IC50 value for D-Ara was estimated to be 7.5 mM, which surpassed that of the potent glycolytic inhibitor 2-deoxy-D-glucose (19.5 mM) used as a positive control. The inhibitory effect of D-Ara was also observed in animals cultured in axenic conditions using a chemically defined medium; this excluded the possible influence of E. coli.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:16:00 GMT 2025
by
admin
on
Mon Mar 31 18:16:00 GMT 2025
|
| Record UNII |
F0W6ETZ4E5
|
| Record Status |
FAILED
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Systematic Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
233-708-5
Created by
admin on Mon Mar 31 18:16:00 GMT 2025 , Edited by admin on Mon Mar 31 18:16:00 GMT 2025
|
PRIMARY | |||
|
41546-26-3
Created by
admin on Mon Mar 31 18:16:00 GMT 2025 , Edited by admin on Mon Mar 31 18:16:00 GMT 2025
|
ALTERNATIVE | |||
|
10323-20-3
Created by
admin on Mon Mar 31 18:16:00 GMT 2025 , Edited by admin on Mon Mar 31 18:16:00 GMT 2025
|
PRIMARY | |||
|
66308
Created by
admin on Mon Mar 31 18:16:00 GMT 2025 , Edited by admin on Mon Mar 31 18:16:00 GMT 2025
|
PRIMARY | |||
|
46983
Created by
admin on Mon Mar 31 18:16:00 GMT 2025 , Edited by admin on Mon Mar 31 18:16:00 GMT 2025
|
PRIMARY | |||
|
17108
Created by
admin on Mon Mar 31 18:16:00 GMT 2025 , Edited by admin on Mon Mar 31 18:16:00 GMT 2025
|
PRIMARY | |||
|
28697-53-2
Created by
admin on Mon Mar 31 18:16:00 GMT 2025 , Edited by admin on Mon Mar 31 18:16:00 GMT 2025
|
ALTERNATIVE | |||
|
DTXSID70858954
Created by
admin on Mon Mar 31 18:16:00 GMT 2025 , Edited by admin on Mon Mar 31 18:16:00 GMT 2025
|
PRIMARY | |||
|
F0W6ETZ4E5
Created by
admin on Mon Mar 31 18:16:00 GMT 2025 , Edited by admin on Mon Mar 31 18:16:00 GMT 2025
|
PRIMARY | |||
|
46994
Created by
admin on Mon Mar 31 18:16:00 GMT 2025 , Edited by admin on Mon Mar 31 18:16:00 GMT 2025
|
PRIMARY | |||
|
m2020
Created by
admin on Mon Mar 31 18:16:00 GMT 2025 , Edited by admin on Mon Mar 31 18:16:00 GMT 2025
|
PRIMARY | Merck Index |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
RACEMATE -> ENANTIOMER |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|